About Centogene
Centogene is a company based in Rostock (Germany) founded in 2006.. Centogene has raised $28.02 million across 3 funding rounds from investors including Deutsche Private Equity, Careventures and TVM Capital Life Science. The company has 11 employees as of April 06, 2024. Centogene offers products and services including CentoGenome, CentoXome, MOx, and NGS Panels. Centogene operates in a competitive market with competitors including Invitae, Strand Life Sciences, Myriad Genetics, Genome Medical and Fulgent Genetics, among others.
- Headquarter Rostock, Germany
- Employees 11 as on 06 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Centogene N.V.
-
Annual Revenue
$52.47 M5.17as on Dec 31, 2023
-
Net Profit
$-38.41 M-14.79as on Dec 31, 2023
-
EBITDA
$-34.07 M-12.21as on Dec 31, 2023
-
Total Equity Funding
$28.02 M (USD)
in 3 rounds
-
Latest Funding Round
$16.78 M (USD), Post-IPO
Feb 01, 2022
-
Investors
Deutsche Private Equity
& 3 more
-
Employee Count
11
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Centogene
Centogene is a publicly listed company on the OTC with ticker symbol CNTGF in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Centogene
Centogene offers a comprehensive portfolio of products and services, including CentoGenome, CentoXome, MOx, and NGS Panels. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Whole genome sequencing for comprehensive rare disease diagnostics
Whole exome sequencing for cost-effective patient diagnosis
Multiomics platform for deeper biological process understanding
Targeted panels for hereditary condition diagnostics
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Sales and Marketing
7 people
Member Team
6 people
Data Analysis and Operations Team
6 people
Human Resources and Administration
5 people
Product Management Team
4 people
Head Team
3 people
Operations Team
2 people
Unlock access to complete
Funding Insights of Centogene
Centogene has successfully raised a total of $28.02M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $16.78 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $16.8M
-
First Round
First Round
(13 Jun 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Post-IPO - Centogene | Valuation |
investors |
|
| Jul, 2020 | Amount | Post-IPO - Centogene | Valuation |
investors |
|
| Jun, 2017 | Amount | Series A - Centogene | Valuation | TVM Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Centogene
Centogene has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Deutsche Private Equity, Careventures and TVM Capital Life Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Founded Year | Domain | Location | |
|
Careventures is focused on healthcare investments across Europe.
|
Founded Year | Domain | Location | |
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Centogene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Centogene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Centogene Comparisons
Competitors of Centogene
Centogene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Invitae, Strand Life Sciences, Myriad Genetics, Genome Medical and Fulgent Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Genomic testing services are provided clinically and directly to consumers.
|
|
| domain | founded_year | HQ Location |
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Centogene
Frequently Asked Questions about Centogene
When was Centogene founded?
Centogene was founded in 2006 and raised its 1st funding round 11 years after it was founded.
Where is Centogene located?
Centogene is headquartered in Rostock, Germany. It is registered at Rostock, Mecklenburg-vorpommern, Germany.
Is Centogene a funded company?
Centogene is a funded company, having raised a total of $28.02M across 3 funding rounds to date. The company's 1st funding round was a Series A of $28.02M, raised on Jun 13, 2017.
How many employees does Centogene have?
As of Apr 06, 2024, the latest employee count at Centogene is 11.
What is the annual revenue of Centogene?
Annual revenue of Centogene is $52.47M as on Dec 31, 2023.
What does Centogene do?
Founded in 2006 in Rostock, Germany, operations focus on the genetic diagnostics sector. A database called CentoMD is maintained, containing disease-causing mutations with a phenotype-genotype search tool based on the Human Phenotype Ontology. Genetic panel tests and single mutation tests are offered, alongside analytical services for neonatal screening of congenital diseases, as well as detection of breast cancer, mitochondrial disorders, infertility, stroke, vascular dementia, somatic cancer mutations, and Fabrys disease.
Who are the top competitors of Centogene?
Centogene's top competitors include Strand Life Sciences, Fulgent Genetics and Myriad Genetics.
What products or services does Centogene offer?
Centogene offers CentoGenome, CentoXome, MOx, and NGS Panels.
Is Centogene publicly traded?
Yes, Centogene is publicly traded on OTC under the ticker symbol CNTGF.
Who are Centogene's investors?
Centogene has 4 investors. Key investors include Deutsche Private Equity, Careventures, TVM Capital Life Science, and Crédit Mutuel Equity.
What is Centogene's ticker symbol?
The ticker symbol of Centogene is CNTGF on OTC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.